Guerra Pan Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Guerra Pan Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Sell	7,182 -75	-1%	-$10.1K	0.63%	36
2026 Q1	$927K	Sell	7,257 -57	-0.8%	-$7.12K	0.57%	42
2025 Q4	$892K	Hold	7,314	–	–	0.53%	42
2025 Q3	$733K	Sell	7,314 -89	-1%	-$8.02K	0.44%	48
2025 Q2	$614K	Sell	7,403 -349	-5%	-$27.8K	0.4%	52
2025 Q1	$629K	Hold	7,752	–	–	0.49%	54
2024 Q4	$698K	Hold	7,752	–	–	0.51%	50
2024 Q3	$766K	Buy	7,752 +480	+7%	+$47.2K	0.61%	46
2024 Q2	$674K	Hold	7,272	–	–	0.56%	48
2024 Q1	$690K	Sell	7,272 -176	-2%	-$16.3K	0.64%	47
2023 Q4	$665K	Sell	7,448 -520	-7%	-$38.6K	0.63%	49
2023 Q3	$582K	Hold	7,968	–	–	0.67%	46
2023 Q2	$663K	Buy	7,968 +177	+2%	+$14.8K	0.74%	44
2023 Q1	$594K	Sell	7,791 -100	-1%	-$8.3K	0.74%	44
2022 Q4	$655K	Hold	7,891	–	–	0.9%	39
2022 Q3	$624K	Hold	7,891	–	–	0.91%	40
2022 Q2	$640K	Hold	7,891	–	–	0.79%	42
2022 Q1	$599K	Hold	7,891	–	–	0.72%	45
2021 Q4	$883K	Buy	+7,891	New	+$952K	0.88%	34

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Guerra Pan Advisors's XBI Position: Q2 2026 in Review

Guerra Pan Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 1% in Q2 2026, selling an estimated $10.1K and leaving 7,182 shares worth $1.14M. The position accounts for 0.63% of the portfolio, ranked #36.

Guerra Pan Advisors first reported a position in XBI in Q4 2021 and has held it in 19 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Guerra Pan Advisors held 7,182 shares of State Street SPDR S&P Biotech ETF worth $1.14M as of Q2 2026.
Guerra Pan Advisors sold 75 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $10.1K.
State Street SPDR S&P Biotech ETF made up 0.63% of Guerra Pan Advisors's portfolio in Q2 2026, its #36 holding.
Guerra Pan Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 19 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Guerra Pan Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.